Dries Cardoen, Nelson Labs - Qepler Summits And Conferences

Dries Cardoen

Team Responsible of E&L Study Directors - Inhalation/Topical/Transdermal products
Nelson Labs
Leuven, Belgium
We are a leading, global testing lab specializing in expert advisory and testing solutions for medical device, pharmaceutical, tissue & biologics companies

Dries Cardoen received his Ph.D. from the Faculty of Biology at the University of Leuven (Belgium) in 2011.

After his academic career as a post-doctoral researcher, he started at Nelson Labs (formerly Toxikon Europe) in 2013 as study director in the Extractables & Leachables Department.

From the start, he specialized in E&L projects of inhalation drug products. He is currently leading the team of study directors that is specialized in E&L testing of inhalation drug products and topical and transdermal drug products.

Related Sessions:

Extractables & Leachables
Summit 2019

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 15 Oct 2019
  • Berlin, DE
  • Pharma
Day 2: Wednesday, 16 October 2019
CASE STUDY: Errors in chromatographic screening
  • The risk of omission: omitting a compound in chromatographic screening is a fatal error, as the assessment of the extractables or leachables profile is irreversibly compromised by committing the error
  • The risk of inexact identification: if the wrong identity for a compound is secured, then clearly the substance’s impact on the devices suitability cannot be assessed as the link between the extractable and its relevant toxicological information cannot be established
  • The risk of inaccurate and imprecise quantitation in chromatographic screening processes
View Details